Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Ugeskr Laeger ; 183(26)2021 06 28.
Artigo em Dinamarquês | MEDLINE | ID: mdl-34219637

RESUMO

Swimming-induced pulmonary oedema (SIPE) is a rare condition, where hemodynamic changes associated with immersion in water and swimming induces pulmonary oedema. Here, we report a case with a 57-year old very fit female triathlete experiencing critical lung edema during low intensity open water swimming. We speculate, that SIPE in this particular patient was caused by a combination of factors: 1) Stress-induced diastolic dysfunction, 2) tendency to vasoconstriction upon stress and 3) possibly paroxysmal atrial fibrillation induced by increased atrial pressure during the event.


Assuntos
Edema Pulmonar , Feminino , Hemodinâmica , Humanos , Pessoa de Meia-Idade , Edema Pulmonar/diagnóstico por imagem , Edema Pulmonar/etiologia , Natação , Água
3.
Cancer Cell ; 24(3): 379-93, 2013 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-24029234

RESUMO

Lysosomal membrane permeabilization and subsequent cell death may prove useful in cancer treatment, provided that cancer cell lysosomes can be specifically targeted. Here, we identify acid sphingomyelinase (ASM) inhibition as a selective means to destabilize cancer cell lysosomes. Lysosome-destabilizing experimental anticancer agent siramesine inhibits ASM by interfering with the binding of ASM to its essential lysosomal cofactor, bis(monoacylglycero)phosphate. Like siramesine, several clinically relevant ASM inhibitors trigger cancer-specific lysosomal cell death, reduce tumor growth in vivo, and revert multidrug resistance. Their cancer selectivity is associated with transformation-associated reduction in ASM expression and subsequent failure to maintain sphingomyelin hydrolysis during drug exposure. Taken together, these data identify ASM as an attractive target for cancer therapy.


Assuntos
Transformação Celular Neoplásica/metabolismo , Inibidores Enzimáticos/farmacologia , Lisossomos/metabolismo , Esfingolipídeos/metabolismo , Esfingomielina Fosfodiesterase/antagonistas & inibidores , Animais , Antineoplásicos/farmacologia , Antineoplásicos/toxicidade , Morte Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Resistencia a Medicamentos Antineoplásicos , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/toxicidade , Feminino , Proteínas de Choque Térmico HSP70/genética , Proteínas de Choque Térmico HSP70/metabolismo , Humanos , Indóis/farmacologia , Indóis/toxicidade , Camundongos , Camundongos Transgênicos , Fenótipo , Compostos de Espiro/farmacologia , Compostos de Espiro/toxicidade , Tocoferóis/farmacologia , Ensaios Antitumorais Modelo de Xenoenxerto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA